CD8+ memory T cells can recognize and destroy tumor cells with no TAP or beta-2 microglobulin (β2M) at all, driven by Sec62-mediated import of peptides into the ER and chaperone-facilitated stabilization of free MHC-I heavy chains. The gene discussed is CD8A; the disease is neoplasm.